Bioretec completed a 7,2 M€ equity funding round

Bioretec´s investment round was oversubscribed and ended during the first subscribtion day

”We are extremely delighted about the investors’ interest and trust towards our company and our innovative products. I would like to express my warmest gratitude to all the subscribers as well as to the professional team of Springvest for their work in coordinating and marketing of our investment round. We strongly believe that our products can provide considerable benefits to patients across the world – and accordingly this will lead into increased shareholder value”, summarizes Tomi Numminen, Bioretec´s Chairman of the Board of Directors.

The company focuses to the registration and commercialization of RemeOs™ trauma screws

”Our new production facilities are almost ready and RemeOs™ Screw registration process has been started with the U.S. FDA. The United States Food and Drug Administration FDA granted Breakthrough Device Designation for Bioretec’s bioresorbable RemeOs™ Screw and the on-going interactive process with the FDA forms a foundation to our registration process. We have a talented and motivated team and our groundbreaking pipeline consits of various next-generation bioresorbable products. We are accelerating forward to reach our operative targets”, comments Timo Lehtonen, Bioretec’s CEO.

Bioretec investment round was organized by Springvest Oy

Bioretec investment round was organized by Springvest Oy”We have known Bioretec team extremely well already for years and wanted to organize this exciting investment round. We knew that Bioretec shares shall show strong demand  in the markets”, states Päivi Malinen, Springvest’s CEO.

Timo Lehtonen, CEO, tel. +358 50 433 8493

Tomi Numminen, Chairman of the Board of Directors, tel. +358 40 581 213

Bioretec Ltd. is a medical device company focusing on developing strong, safe and reliable bioabsorbable and bioresorbable implants for pediatric and adult orthopedics. Bioretec´s products are used worldwide, and the company continuously develops materials and products for load-bearing clinical applications.

RemeOs™ biometal implants

Representing breakthrough technology, bioresorbable RemeOs™ Screw metal implants are made of a unique and patented bioresorbable metal alloy. The alloy is made of magnesium, calcium and zinc, which are all essential elements in our body’s natural ossification process